ID: ALA404578

Max Phase: Preclinical

Molecular Formula: C10H9N3O2

Molecular Weight: 203.20

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(O)c1cn(Cc2ccccc2)nn1

Standard InChI:  InChI=1S/C10H9N3O2/c14-10(15)9-7-13(12-11-9)6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H,14,15)

Standard InChI Key:  MIGIDQCWBSDLTO-UHFFFAOYSA-N

Associated Targets(non-human)

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Fe(3+)-Zn(2+) purple acid phosphatase 65 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 203.20Molecular Weight (Monoisotopic): 203.0695AlogP: 1.02#Rotatable Bonds: 3
Polar Surface Area: 68.01Molecular Species: ACIDHBA: 4HBD: 1
#RO5 Violations: 0HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.02CX Basic pKa: CX LogP: 1.79CX LogD: -1.68
Aromatic Rings: 2Heavy Atoms: 15QED Weighted: 0.81Np Likeness Score: -1.84

References

1. Aufort M, Herscovici J, Bouhours P, Moreau N, Girard C..  (2008)  Synthesis and antibiotic activity of a small molecules library of 1,2,3-triazole derivatives.,  18  (3): [PMID:18086525] [10.1016/j.bmcl.2007.11.111]
2. Hussein WM, Feder D, Schenk G, Schenk G, Guddat LW, McGeary RP..  (2019)  Synthesis and evaluation of novel purple acid phosphatase inhibitors.,  10  (1): [PMID:30774855] [10.1039/C8MD00491A]

Source